Abstract
Background
Low oesophageal temperatures (OTs) during cryoballoon pulmonary vein isolation (PVI) have been associated with complications. This study assessed the incidence of low OT in clinical practice during cryoballoon PVI and verified possible predictive values for low OT.
Methods
Consecutive patients who underwent PVI using the second-generation cryoballoon were retrospectively included. The distance from the oesophagus to the different pulmonary veins (PVs) (OP distance), body mass index (BMI), sex, age, balloon temperature and application time were studied as potential predictors of low OTs. Computed tomography was performed before the procedure to determine the OP distance. OT was measured using an oesophageal temperature probe. Applications were ended prematurely if the OT reached <16 °C. Low and ultralow OT were defined as OT <20 and <16 °C respectively.
Results
Two hundred and four patients were included. Low OT was observed in 54 patients (26%) and 27 patients (13%) reached ultralow OTs. OP distance was the only predictor of low OTs after multivariate analysis. A cut-off value of 19 mm showed 96.2% sensitivity and 37.8% specificity in predicting low OTs. No clinically relevant relation was found between low OTs and BMI, age, sex, balloon temperature or application duration.
Conclusions
The incidence of low OT was 26% for cryoballoon PVI. OP distance was the only predictor of low OTs. Since an OP distance <19 mm was present in all patients in at least one PV, we recommend routine OT measurement during PVI cryoballoon therapy to prevent oesophagus-related complications.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Hesselink, T. 2
; Scholten, M. F. 2
; Kraaier, K. 2
; Bouman, D. E. 3 ; Brusse-Keizer, M. 4
; Stevenhagen, Y. J. 2
; van Dessel, P. F. H. M. 2
; ten Haken, B. 5
; Grandjean, J. G. 2
; van Opstal, J. M. 2 1 Medisch Spectrum Twente, Thoraxcenter Twente, Enschede, The Netherlands (GRID:grid.415214.7) (ISNI:0000 0004 0399 8347); University of Twente, Department of Magnetic Detection and Interventions, Enschede, The Netherlands (GRID:grid.6214.1) (ISNI:0000 0004 0399 8953)
2 Medisch Spectrum Twente, Thoraxcenter Twente, Enschede, The Netherlands (GRID:grid.415214.7) (ISNI:0000 0004 0399 8347)
3 Medisch Spectrum Twente, Radiology Department, Enschede, The Netherlands (GRID:grid.415214.7) (ISNI:0000 0004 0399 8347)
4 Medisch Spectrum Twente, Medical School Twente, Enschede, The Netherlands (GRID:grid.415214.7) (ISNI:0000 0004 0399 8347)
5 University of Twente, Department of Magnetic Detection and Interventions, Enschede, The Netherlands (GRID:grid.6214.1) (ISNI:0000 0004 0399 8953)





